76 Recruiting Studies Using Tirzepatide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Tirzepatide
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
📍 Valley Clinical Trials, Inc. — Northridge, California
Overweight
View Study & Checklist ➔A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
📍 CenExel iResearch, LLC — Decatur, Georgia
Obesity
View Study & Checklist ➔Tirzepatide for Obesity and Meth Use Disorder
📍 UT Southwestern Medical Center — Dallas, Texas
Obesity
View Study & Checklist ➔GLP-1s to Enhance Lasting Optimal Weight
📍 Wake Forest University Health Sciences — Winston-Salem, North Carolina
Obesity
View Study & Checklist ➔A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
📍 Pinnacle Research Group — Anniston, Alabama
Obesity
View Study & Checklist ➔The Long COVID Treatment Trial
📍 Scripps Research — La Jolla, California
Long COVID
View Study & Checklist ➔GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
📍 Vanderbilt University Medical Center — Nashville, Tennessee
Severe Obesity
View Study & Checklist ➔A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
📍 Cahaba Research - Trussville — Birmingham, Alabama
Type 2 Diabetes
View Study & Checklist ➔A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
📍 Medical Advancement Centers of Arizona — Tempe, Arizona
Obesity
View Study & Checklist ➔A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
📍 Sansum Diabetes Research Institute — Santa Barbara, California
Type 1 Diabetes
View Study & Checklist ➔Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Obesity
View Study & Checklist ➔A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
📍 Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC — Gilbert, Arizona
Obesity
View Study & Checklist ➔A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
📍 The Institute for Liver Health II dba Arizona Clinical Trials - Mesa — Chandler, Arizona
Obesity
View Study & Checklist ➔Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
📍 Brigham and Women's Hospital — Boston, Massachusetts
Type 2 Diabetes
View Study & Checklist ➔Bariatric Surgery vs. Semaglutide vs. Tirzepatide
📍 The Cleveland Clinic — Cleveland, Ohio
Obesity and Obesity-related Medical Conditions
View Study & Checklist ➔A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
📍 Medical Advancement Centers of Arizona — Phoenix, Arizona
Type 2 Diabetes
View Study & Checklist ➔A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
📍 University Clinical Research-DeLand LLC, d/b/a Accel Research — DeLand, Florida
Obesity
View Study & Checklist ➔Anti-obesity Pharmacotherapy and Inflammation
📍 LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO — New Orleans, Louisiana
Obesity
View Study & Checklist ➔A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
📍 Kaiser Permanente Bonita Medical Offices — Bonita, California
Type 1 Diabetes
View Study & Checklist ➔A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
📍 Pinnacle Research Group, LLC — Anniston, Alabama
Obesity
View Study & Checklist ➔CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
📍 IMSS Clínica Río Magdalena — Mexico City, Mexico City
Psoriatic Arthritis
View Study & Checklist ➔Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Endometrial Cancer
View Study & Checklist ➔Tirzepatide for Treatment of CCCA
📍 Johns Hopkins Outpatient Center — Baltimore, Maryland
Central Centrifugal Cicatricial Alopecia (CCCA)
View Study & Checklist ➔Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
📍 Biomed Research Unit #90067-102 — Los Angeles, California
Obesity and Overweight
View Study & Checklist ➔Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
📍 Cedars Sinai Medical Center — Beverly Hills, California
Pouch, Ileal
View Study & Checklist ➔GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
📍 Cleveland Clinic — Cleveland, Ohio
COPD
View Study & Checklist ➔Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Lung Cancer
View Study & Checklist ➔A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
📍 Northwestern University — Chicago, Illinois
Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia
View Study & Checklist ➔GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
📍 Noom, Inc. — Princeton, New Jersey
Obesity & Overweight
View Study & Checklist ➔Tirzepatide in the Treatment of Cannabis Use Disorder
📍 MacAnxiety Research Centre — Hamilton, Ontario
Cannabis Use Disorder, Moderate
View Study & Checklist ➔The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
📍 University of Virginia — Charlottesville, Virginia
Obesity & Overweight
View Study & Checklist ➔A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
📍 Institut de Recherches Cliniques de Montréal — Montreal, Quebec
Type 1 Diabetes
View Study & Checklist ➔A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
📍 The Institute for Liver Health II dba Arizona Clinical Trials - Mesa — Chandler, Arizona
Obesity
View Study & Checklist ➔The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
📍 Mayo Clinic in Florida — Jacksonville, Florida
Obesity
View Study & Checklist ➔Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
📍 Clinical and Translational Research Unit — Palo Alto, California
Obesity
View Study & Checklist ➔2024 Tirzepatide-Bariatric Surgery
📍 University of Kentucky — Lexington, Kentucky
Obesity and Obesity-related Medical Conditions
View Study & Checklist ➔Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
📍 Trinitas Comprehensive Cancer Center — Elizabeth, New Jersey
Hormone Receptor-Positive Breast Cancer
View Study & Checklist ➔Tirzepatide in PWS, HO and GNSO
📍 Children's Minnesota — Saint Paul, Minnesota
Prader-Willi Syndrome
View Study & Checklist ➔Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Diabetes
View Study & Checklist ➔Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
📍 Massachusetts General Hospital — Boston, Massachusetts
Obesity
View Study & Checklist ➔Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
📍 University of Miami — Miami, Florida
Crohn Disease
View Study & Checklist ➔A Study of a Weight Loss Intervention in People With Endometrial Cancer
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Endometrial Cancer
View Study & Checklist ➔Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
📍 Weill Cornell Medicine — New York, New York
Obesity (Disorder)
View Study & Checklist ➔Multi-Site Trial of Tirzepatide for Smoking Cessation
📍 Keck School of Medicine, University of Southern California — Los Angeles, California
Smoking Cessation
View Study & Checklist ➔A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
📍 Southern California Research Center — Coronado, California
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
View Study & Checklist ➔Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
📍 University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
Mild Autonomous Cortisol Secretion (MACS)
View Study & Checklist ➔Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
📍 Gateway Community Services — Jacksonville, Florida
Opioid Use Disorder
View Study & Checklist ➔Tirzepatide Weight Loss for MRD+ Early Breast Cancer
📍 Baylor University Medical Center, Baylor Charles A Sammons Cancer Center — Dallas, Texas
Breast Cancer
View Study & Checklist ➔Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
📍 University of Michigan — Ann Arbor, Michigan
Lipodystrophy, Partial
View Study & Checklist ➔Tirzepatide in Idiopathic Intracranial Hypertension Trial
📍 Duke University Medical Center — Durham, North Carolina
Idiopathic Intracranial Hypertension (IIH)
View Study & Checklist ➔A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
📍 AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale — Avondale, Arizona
Psoriatic Arthritis
View Study & Checklist ➔GLP-1R Actions on Muscle and the Skeleton
📍 Pennington Biomedical Research Center — Baton Rouge, Louisiana
Musculoskeletal Abnormalities
View Study & Checklist ➔Tirzepatide in MetALD
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Metabolic Alcohol-associated Liver Disease
View Study & Checklist ➔Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Alcohol Use Disorder (AUD)
View Study & Checklist ➔Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
📍 University Health System Texas Diabetic Institute — San Antonio, Texas
Type 2 Diabetes (Adult Onset)
View Study & Checklist ➔A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
📍 MFA Clinical Research — Tuscaloosa, Alabama
Metabolic Dysfunction-Associated Steatotic Liver Disease
View Study & Checklist ➔Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
📍 Cedars-Sinai Medical Center — Beverly Hills, California
Crohn Disease (CD)
View Study & Checklist ➔Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
📍 Johns Hopkins University — Baltimore, Maryland
Obesity and Overweight
View Study & Checklist ➔Study of Tirzepatide for Recovery and Alcohol Use Management
📍 Brigham and Women's Hospital — Boston, Massachusetts
Alcohol Use Disorder (AUD)
View Study & Checklist ➔Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
📍 University of Texas Health Science Center at San Antonio — San Antonio, Texas
Obesity Prevention
View Study & Checklist ➔Incretin Therapies in Obesity-related HFpEF
📍 Columbia University Irving Medical Center (CUIMC) / NewYork Presbyterian Hospital (NYP) — New York, New York
Heart Failure, Diastolic
View Study & Checklist ➔Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
📍 Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute) — Torrance, California
Type II Diabetes
View Study & Checklist ➔Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
📍 City of Hope Medical Center — Duarte, California
Prostate Carcinoma
View Study & Checklist ➔A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
📍 Children's Hospital Los Angeles — Los Angeles, California
Obesity
View Study & Checklist ➔Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Acute Lymphoblastic Leukemia
View Study & Checklist ➔TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
📍 Cleveland Clinic — Cleveland, Ohio
Atrial Fibrillation
View Study & Checklist ➔Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
📍 Digestive Health Specialists — Dothan, Alabama
Ulcerative Colitis
View Study & Checklist ➔A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
📍 Medical Dermatology Specialists — Phoenix, Arizona
Psoriasis
View Study & Checklist ➔Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
📍 University of New Mexico Health Sciences Center — Albuquerque, New Mexico
MASLD
View Study & Checklist ➔Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
📍 University of Colorado - Anschutz Medical Campus — Aurora, Colorado
Autosomal Dominant Polycystic Kidney
View Study & Checklist ➔Tirzepatide in Obesity-Driven Endometrial Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Endometrial Cancer
View Study & Checklist ➔Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
📍 Stanford University — Palo Alto, California
Diabetes Mellitus, Type 2
View Study & Checklist ➔Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
📍 Digestive Health Specialists — Dothan, Alabama
Crohn's Disease
View Study & Checklist ➔Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Colorectal Cancer Prevention
View Study & Checklist ➔A Study to Evaluate ALN-2232 in Participants With Obesity
📍 Clinical Trial Site — Mount Royal,
Obesity
View Study & Checklist ➔Tirzepatide for Alcohol Use Disorder
📍 Keck School of Medicine, University of Southern California — Los Angeles, California
Alcohol Use Disorder
View Study & Checklist ➔